ASXL1 and acute myeloid leukemia: Somatic mutations in DNMT3A, TET2, and ASXL1 (referred to as “DTA” mutations) are commonly found in AML patients but are also seen in clinically asymptomatic individuals with increased prevalence with aging (27–30).